Harold Bernstein

Companies

• Maze Therapeutics, Inc.President Jan 30, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMaze Therapeutics, Inc. MAZE0 shares²Sep 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 4, 2026Sold 9,705 shares at $26.22 of Maze Therapeutics, Inc.²
• Sep 3, 2026Sold 59 shares at $25.78 of Maze Therapeutics, Inc.³
• Sep 3, 2026Sold 5,130 shares at $26.01 of Maze Therapeutics, Inc.³
• Sep 2, 2026Sold 625 shares at $27.12 of Maze Therapeutics, Inc.³
• Sep 2, 2026Sold 4,481 shares at $26.38 of Maze Therapeutics, Inc.³
• Sep 1, 2026Exercised options 20,000 shares of Maze Therapeutics, Inc.⁴
• Sep 1, 2026Sold 16,141 shares at $26.36 of Maze Therapeutics, Inc.⁴
• Sep 1, 2026Exercised options 16,141 shares at $10.42 of Maze Therapeutics, Inc.⁴
• Aug 13, 2026Sold 16,142 shares at $27.61 of Maze Therapeutics, Inc.⁵
• Aug 13, 2026Exercised options 16,142 shares at $10.42 of Maze Therapeutics, Inc.⁵
• Jul 1, 2026Sold 1,200 shares at $30.34 of Maze Therapeutics, Inc.⁶
• Jul 1, 2026Sold 13,409 shares at $29.87 of Maze Therapeutics, Inc.⁶
• Jul 1, 2026Exercised options 14,609 shares at $10.42 of Maze Therapeutics, Inc.⁶
• Jun 1, 2026Sold 1,600 shares at $26.36 of Maze Therapeutics, Inc.⁷
• Jun 1, 2026Sold 13,253 shares at $25.57 of Maze Therapeutics, Inc.⁷
• Jun 1, 2026Exercised options 14,853 shares at $10.42 of Maze Therapeutics, Inc.⁷
• May 14, 2026Sold 15,000 shares at $26.22 of Maze Therapeutics, Inc.⁸
• May 14, 2026Exercised options 15,000 shares at $10.42 of Maze Therapeutics, Inc.⁸
• Apr 1, 2026Sold 300 shares at $31.07 of Maze Therapeutics, Inc.⁹
• Apr 1, 2026Sold 3,348 shares at $30.06 of Maze Therapeutics, Inc.⁹
• Apr 1, 2026Sold 11,352 shares at $29.24 of Maze Therapeutics, Inc.⁹
• Apr 1, 2026Exercised options 15,000 shares at $10.42 of Maze Therapeutics, Inc.⁹
• Mar 20, 2026Sold 5,044 shares at $50.02 of Maze Therapeutics, Inc.¹⁰
• Mar 20, 2026Sold 3,795 shares at $49.32 of Maze Therapeutics, Inc.¹⁰
• Mar 20, 2026Sold 6,161 shares at $48.20 of Maze Therapeutics, Inc.¹⁰